| Value | Category | Cases | |
|---|---|---|---|
| 1 | Oral PrEP only | 99 |
68.8%
|
| 2 | 2 monthly Injectable (im) cabotegravir only | 43 |
29.9%
|
| 3 | DapiRing Only | 0 |
0%
|
| 4 | 6 monthly subcutaneous lenocapovir | 2 |
1.4%
|
| 96 | Other | 0 |
0%
|
| Sysmiss | 6886 |